PathogenDx

About:

Arizona-based PathogenDx creates testing solutions that rapidly identify bacterial, fungal and viral threats—helping save money and lives.

Website: http://www.pathogendx.com/

Top Investors: Salveo Capital, Cresco Capital Partners, HALLEY Venture Partners, Flatiron Partners, Canopy Ventures

Description:

PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or Realtime PCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation.